ChartMill · Aug 28, 2026
Friday's session: top gainers and losers
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
AE
NASDAQ · AEMD
Aethlon Medical, Inc.
Healthcare · Medical - Devices
$1.84
Down-$0.22 (-10.68%)
Updated Sep 2, 2026, 5:35 AM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.53M
- P/E ratio
- -0.14
- Dividend yield
- 0.00%
- 52-week range
- $0.54 – $21.00
- Volume
- 295.97K
- Avg. volume
- 125.16K
Price performance
AEMD price history
1M range · 21 trading sessions · Daily adjusted prices
AEMD closed at $1.84 after 21 trading sessions, down 47.73% for the selected period.
- Last close
- $1.84
- Period change
- -47.73%
- Period low
- $1.84
- Period high
- $3.52
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 1, 2026 | $1.90 | $2.00 | $1.81 | $1.84 | 295.97K |
| Aug 31, 2026 | $2.29 | $2.32 | $1.92 | $2.06 | 849.65K |
| Aug 28, 2026 | $2.92 | $3.29 | $2.44 | $2.49 | 45.12M |
| Aug 27, 2026 | $2.24 | $2.35 | $2.17 | $2.17 | 16.55M |
| Aug 26, 2026 | $2.44 | $2.445 | $2.2201 | $2.28 | 28.89K |
| Aug 25, 2026 | $2.70 | $2.76 | $2.33 | $2.40 | 121.11K |
| Aug 24, 2026 | $2.79 | $2.79 | $2.60 | $2.64 | 56.71K |
| Aug 21, 2026 | $2.81 | $2.82 | $2.69 | $2.73 | 37.47K |
| Aug 20, 2026 | $2.73 | $2.8714 | $2.65 | $2.70 | 33.54K |
| Aug 19, 2026 | $2.89 | $2.99 | $2.73 | $2.78 | 52.55K |
| Aug 18, 2026 | $2.94 | $2.9499 | $2.76 | $2.89 | 33.31K |
| Aug 17, 2026 | $2.8908 | $3.06 | $2.87 | $2.935 | 58.85K |
| Aug 14, 2026 | $2.93 | $3.05 | $2.78 | $2.83 | 37.67K |
| Aug 13, 2026 | $3.05 | $3.105 | $2.92 | $2.93 | 19.94K |
| Aug 12, 2026 | $3.09 | $3.09 | $2.91 | $3.04 | 26.5K |
| Aug 11, 2026 | $3.105 | $3.20 | $3.06 | $3.18 | 28.75K |
| Aug 10, 2026 | $3.13 | $3.13 | $3.00 | $3.08 | 15.68K |
| Aug 7, 2026 | $3.02 | $3.27 | $3.00 | $3.15 | 72.91K |
| Aug 6, 2026 | $3.23 | $3.3899 | $2.995 | $3.02 | 76.13K |
| Aug 5, 2026 | $3.52 | $3.70 | $3.21 | $3.25 | 153.99K |
| Aug 4, 2026 | $3.58 | $3.7499 | $3.10 | $3.52 | 163.43K |
Latest AEMD news
The latest Smart Investors Daily articles mentioning AEMD.
Stock researchCompany · Overview
AEMD research
Overview
Company profile and research snapshot.
Company profile
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Hold
- Average target
- $12.62
- Implied upside
- —
- Analysts
- 7
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 14, 2025 | HC Wainwright & Co. | Neutral | — |
| Mar 10, 2025 | HC Wainwright & Co. | Buy | — |
| Feb 19, 2025 | HC Wainwright & Co. | Buy | — |
| Jan 30, 2025 | HC Wainwright & Co. | Buy | — |
| Nov 15, 2024 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 28, 2026
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular session. The company's market cap stands at $10.3 million. Aethlon Medical (NASDAQ:AEMD) shares moved upwards by
Benzinga · Aug 28, 2026
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 41.4% to $7.29 during Friday's pre-market session. The company's market cap stands at $10.3 million. Aethlon Medical (NASDAQ:AEMD) stock moved upwards by
Yahoo · Aug 13, 2026
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a clinical-stage medical therapeutic company, today announced financial results for fiscal first quarter ended June 30, 2026, and provided a corporate update.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
